Cliff Asness's TECH Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 26,087 shares of Bio-Techne Corporation (TECH) worth $1.53 M, representing 0.00% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in TECH, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2018, adding 585,644 shares. Largest reduction occurred in Q1 2019, reducing 681,332 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Bio-Techne Corporation (TECH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Techne Corporation (TECH) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +7,733 | Add 42.13% | 26,087 | $58.81 |
| Q3 2025 | +4,082 | Add 28.60% | 18,354 | $52.80 |
| Q2 2025 | +6,055 | Add 73.69% | 14,272 | $51.45 |
| Q1 2025 | -49,935 | Reduce 85.87% | 8,217 | $57.39 |
| Q4 2024 | +61 | Add 0.11% | 58,152 | $72.03 |
| Q3 2024 | +7,861 | Add 15.65% | 58,091 | $79.07 |
| Q2 2024 | -859 | Reduce 1.68% | 50,230 | $71.65 |
| Q1 2024 | -9,272 | Reduce 15.36% | 51,089 | $69.87 |
| Q4 2023 | +18,746 | Add 45.05% | 60,361 | $77.16 |
| Q3 2023 | +5,392 | Add 14.89% | 41,615 | $68.07 |
| Q2 2023 | -46,404 | Reduce 56.16% | 36,223 | $81.00 |
| Q1 2023 | -82,154 | Reduce 49.86% | 82,627 | $73.50 |
| Q4 2022 | +18,957 | Add 13.00% | 164,781 | $82.80 |
| Q3 2022 | -16,264 | Reduce 10.03% | 145,824 | $71.00 |
| Q2 2022 | -9,280 | Reduce 5.42% | 162,088 | $85.40 |
| Q1 2022 | -70,492 | Reduce 29.15% | 171,368 | $108.26 |
| Q4 2021 | +59,764 | Add 32.82% | 241,860 | $127.20 |
| Q3 2021 | +44,168 | Add 32.02% | 182,096 | $121.14 |
| Q2 2021 | -41,288 | Reduce 23.04% | 137,928 | $111.64 |
| Q1 2021 | -46,192 | Reduce 20.49% | 179,216 | $95.48 |
| Q4 2020 | -604 | Reduce 0.27% | 225,408 | $79.37 |
| Q3 2020 | -32,068 | Reduce 12.43% | 226,012 | $61.93 |
| Q2 2020 | -132,524 | Reduce 33.93% | 258,080 | $63.92 |
| Q1 2020 | +80,172 | Add 25.83% | 390,604 | $47.41 |
| Q4 2019 | -184,972 | Reduce 37.34% | 310,432 | $54.35 |
| Q3 2019 | -289,164 | Reduce 36.86% | 495,404 | $48.92 |
| Q2 2019 | -25,380 | Reduce 3.13% | 784,568 | $51.69 |
| Q1 2019 | -681,332 | Reduce 45.69% | 809,948 | $49.55 |
| Q4 2018 | +585,644 | Add 64.67% | 1.49 M | $36.18 |
| Q3 2018 | +451,784 | Add 99.54% | 905,636 | $51.03 |
| Q2 2018 | +235,392 | Add 107.75% | 453,852 | $36.99 |
| Q1 2018 | +183,116 | Add 518.10% | 218,460 | $37.76 |
| Q4 2017 | +9,996 | Add 39.44% | 35,344 | $32.23 |
| Q3 2017 | -4,876 | Reduce 16.13% | 25,348 | $30.22 |
| Q2 2017 | -608 | Reduce 1.97% | 30,224 | $29.38 |
| Q1 2017 | +30,832 | New Buy | 30,832 | $25.43 |
| Q4 2016 | -18,808 | Sold Out | 0 | $0.00 |
| Q3 2016 | +18,808 | New Buy | 18,808 | $27.38 |
| Q3 2015 | -25,200 | Sold Out | 0 | $0.00 |
| Q1 2015 | -37,772 | Reduce 59.98% | 25,200 | $25.08 |
| Q4 2014 | +62,972 | New Buy | 62,972 | $23.11 |
Cliff Asness's Bio-Techne Corporation Investment FAQs
Cliff Asness first purchased Bio-Techne Corporation (TECH) in Q4 2014, acquiring 62,972 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Bio-Techne Corporation (TECH) for 42 quarters since Q4 2014.
Cliff Asness's largest addition to Bio-Techne Corporation (TECH) was in Q4 2018, adding 1,491,280 shares worth $53.96 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 26,087 shares of Bio-Techne Corporation (TECH), valued at approximately $1.53 M.
As of the Q4 2025 filing, Bio-Techne Corporation (TECH) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Bio-Techne Corporation (TECH) was 1,491,280 shares, as reported at the end of Q4 2018.